Nihay Laham-Karam

2.2k total citations
62 papers, 1.7k citations indexed

About

Nihay Laham-Karam is a scholar working on Molecular Biology, Immunology and Epidemiology. According to data from OpenAlex, Nihay Laham-Karam has authored 62 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 16 papers in Immunology and 10 papers in Epidemiology. Recurrent topics in Nihay Laham-Karam's work include Virus-based gene therapy research (8 papers), Reproductive System and Pregnancy (8 papers) and HIV Research and Treatment (7 papers). Nihay Laham-Karam is often cited by papers focused on Virus-based gene therapy research (8 papers), Reproductive System and Pregnancy (8 papers) and HIV Research and Treatment (7 papers). Nihay Laham-Karam collaborates with scholars based in Finland, United States and Australia. Nihay Laham-Karam's co-authors include Gregory E. Rice, Shaun P. Brennecke, Seppo Ylä‐Herttuala, Eran Bacharach, Klaus Bendtzen, Minna U. Kaikkonen, Chen Au Peh, James McCluskey, Rachel Ehrlich and Scott R. Burrows and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Nihay Laham-Karam

61 papers receiving 1.6k citations

Peers

Nihay Laham-Karam
Daniela Mazzeo United Kingdom
Erin D. Lew United States
H. Sobis Belgium
Christelle Borel Switzerland
Roel Broekhuizen Netherlands
Andrea Reboldi United States
Mary J. Mattapallil United States
Doris Coit United States
Nihay Laham-Karam
Citations per year, relative to Nihay Laham-Karam Nihay Laham-Karam (= 1×) peers Sophie Chabot

Countries citing papers authored by Nihay Laham-Karam

Since Specialization
Citations

This map shows the geographic impact of Nihay Laham-Karam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nihay Laham-Karam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nihay Laham-Karam more than expected).

Fields of papers citing papers by Nihay Laham-Karam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nihay Laham-Karam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nihay Laham-Karam. The network helps show where Nihay Laham-Karam may publish in the future.

Co-authorship network of co-authors of Nihay Laham-Karam

This figure shows the co-authorship network connecting the top 25 collaborators of Nihay Laham-Karam. A scholar is included among the top collaborators of Nihay Laham-Karam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nihay Laham-Karam. Nihay Laham-Karam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jauhiainen, Suvi, Francesca Lazzaroni, Lei Liu Conze, et al.. (2024). Proteomics on human cerebral cavernous malformations reveals novel biomarkers in neurovascular dysfunction for the disease pathology. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1870(5). 167139–167139. 2 indexed citations
2.
Laham-Karam, Nihay, Johanna P. Laakkonen, Seppo Ylä‐Herttuala, et al.. (2024). Cell-Specific Targeting of the Endothelium in the CardioRenal Syndrome. Cardiorenal Medicine. 14(1). 129–135. 1 indexed citations
3.
Laham-Karam, Nihay, Lorena Lucatello, Rosa Maria Lopparelli, et al.. (2024). Establishment and characterization of cytochrome P450 1A1 CRISPR/Cas9 Knockout Bovine Foetal Hepatocyte Cell Line (BFH12). Cell Biology and Toxicology. 40(1). 18–18. 4 indexed citations
4.
Laham-Karam, Nihay, et al.. (2024). Cardiac vein retroinjections provide an efficient approach for global left ventricular gene transfer with adenovirus and adeno-associated virus. Scientific Reports. 14(1). 1467–1467. 4 indexed citations
5.
Ruotsalainen, Anna‐Kaisa, Tiit Örd, Janne Heikkilä, et al.. (2023). Deletion of the murine ortholog of human 9p21.3 locus promotes atherosclerosis by increasing macrophage proinflammatory activity. Frontiers in Cardiovascular Medicine. 10. 1113890–1113890. 5 indexed citations
6.
Kalliokoski, Kari K., Tuomas Selander, Tomi Laitinen, et al.. (2023). Critical limb-threatening ischaemia and microvascular transformation: clinical implications. European Heart Journal. 45(4). 255–264. 8 indexed citations
7.
Khachigian, Levon M., et al.. (2023). Gene Therapeutic Strategies for Peripheral Artery Disease and New Opportunities Provided by Adeno-Associated Virus Vectors. Arteriosclerosis Thrombosis and Vascular Biology. 43(6). 836–851. 16 indexed citations
8.
Niskanen, Henri, et al.. (2023). Hypoxic regulation of hypoxia inducible factor 1 alpha via antisense transcription. Journal of Biological Chemistry. 299(11). 105291–105291. 3 indexed citations
9.
Laham-Karam, Nihay, et al.. (2022). Strategies to improve safety profile of AAV vectors. PubMed. 2. 1054069–1054069. 12 indexed citations
10.
Laham-Karam, Nihay, et al.. (2021). Optimized Protocol for Accurate Titration of Adeno-Associated Virus Vectors. Human Gene Therapy. 32(19-20). 1270–1279. 14 indexed citations
11.
Laham-Karam, Nihay, Tuomas Selander, Petra Korpisalo, et al.. (2020). Efficacy and Safety of Clinical-Grade Human Vascular Endothelial Growth Factor-D ΔNΔC Gene Therapy Containing Residual Replication-Competent Adenoviruses. Human Gene Therapy. 32(13-14). 761–770. 4 indexed citations
12.
Laham-Karam, Nihay, et al.. (2018). Differential but Complementary HIF1α and HIF2α Transcriptional Regulation. Molecular Therapy. 26(7). 1735–1745. 121 indexed citations
13.
Ehrlich, Marcelo, et al.. (2012). p12 Tethers the Murine Leukemia Virus Pre-integration Complex to Mitotic Chromosomes. PLoS Pathogens. 8(12). e1003103–e1003103. 56 indexed citations
14.
Brinkmann, Martin, Nihay Laham-Karam, Rachel Ehrlich, et al.. (2006). Expression of iron transport proteins divalent metal transporter‐1, Ferroportin‐1, HFE and transferrin receptor‐1 in human monocyte‐derived dendritic cells. Cell Biochemistry and Function. 25(3). 287–296. 14 indexed citations
15.
Rohrlich, Pierre‐Simon, Nicolas Fazilleau, Florent Ginhoux, et al.. (2005). Direct recognition by αβ cytolytic T cells of Hfe, a MHC class Ib molecule without antigen-presenting function. Proceedings of the National Academy of Sciences. 102(36). 12855–12860. 36 indexed citations
16.
Kjer‐Nielsen, Lars, Nihay Laham-Karam, Tanya L. Crockford, et al.. (2004). Impact of natural HLA class I polymorphism and the pathway of antigen presentation. Genes and Immunity. 5. 1 indexed citations
17.
Purcell, Anthony W., W.A. Macdonald, Lars Kjer‐Nielsen, et al.. (2004). Natural HLA Class I Polymorphism Controls the Pathway of Antigen Presentation and Susceptibility to Viral Evasion. The Journal of Experimental Medicine. 200(1). 13–24. 135 indexed citations
18.
Laham-Karam, Nihay, et al.. (2004). Mouse HFE inhibits Tf‐uptake and iron accumulation but induces non‐transferrin bound iron (NTBI)‐uptake in transformed mouse fibroblasts. Journal of Cellular Physiology. 202(1). 105–114. 6 indexed citations
19.
Purcell, Anthony W., Jeffrey J. Gorman, Marina García-Peydró, et al.. (2001). Quantitative and Qualitative Influences of Tapasin on the Class I Peptide Repertoire. The Journal of Immunology. 166(2). 1016–1027. 129 indexed citations
20.
Peh, Chen Au, Nihay Laham-Karam, Scott R. Burrows, Yong Zhu, & James McCluskey. (2000). Distinct Functions of Tapasin Revealed by Polymorphism in MHC Class I Peptide Loading. The Journal of Immunology. 164(1). 292–299. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026